臨床婦人科産科70巻8号

2016年08月発行

今月の臨床 婦人科悪性腫瘍規約改訂のポイントと対応─「何が」「なぜ」「どのように」変わったのか

卵巣腫瘍

卵巣がん・卵管がん・原発性腹膜がんのFIGO進行期分類2014の要点と臨床的意義

著者： 小宮山慎一¹

所属機関： ¹東邦大学医療センター大橋病院婦人科

ページ範囲：P.741 - P.747

文献概要

●FIGO2014進行期分類では，卵巣がんは「同一の疾患ではなく，疾患のグループである」と明記され，各組織型に共通した予後因子を採用した．さらに卵巣がんのみならず，原発性腹膜がんと卵管がんも統一した分類となった．

●これらを用いて，世界規模の予後解析を行うためのデータ収集を行うことを志向している．

●ⅠC期の細分類，ⅢA期の細分類，Ⅳ期の亜分類が大きく改変された．

参考文献

1）Prat J : FIGO committee on gynecologic oncology : Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet 124 : 1─5, 2014

2）Piek JM, et al : Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J Pathol 195 : 451─456, 2001

3）Callahan MJ, et al : Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol 25 : 3985─3990, 2007

4）Kindelberger DW, et al : Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma : evidence for a causal relationship. Am J Surg Pathol 31 : 161─169, 2007

5）Vergote I, et al : Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 357 : 176─182, 2001

6）Bakkum-Gamez JN, et al : Influence of intraoperative capsule rupture on outcomes in stage I epithelial ovarian cancer. Obstet Gynecol 113 : 11─17, 2009

7）Chan JK, et al : Prognostic factors for high-risk early-stage epithelial ovarian cancer : a gynecologic oncology group study. Cancer 112 : 2202─2210, 2008

8）Obermair A, et al : A new prognostic model for FIGO stage 1 epithelial ovarian cancer. Gynecol Oncol 104 : 607─611, 2007

9）Ayhan A, et al : Metastatic lymph node number in epithelial ovarian carcinoma : does it have any clinical significance? Gynecol Oncol 108 : 428─432, 2008

10）Cliby WA, et al : Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only? Gynecol Oncol 103 : 797─801, 2006

11）Ferrandina G, et al : Ovarian cancer patients with “node-positive-only” Stage IIIC disease have a more favorable outcome than Stage IIIA/B. Gynecol Oncol 107 : 154─156, 2007

12）Baek SJ, et al : Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer. J Gynecol Oncol 19 : 223─228, 2008

13）Lheureux S, et al : Ovarian cancer treatment : the end of empiricism? Cancer 121 : 3203─3211, 2015